ACC 2017

Latest ACC 2017

FOURIER: Lipid levels and cardiovascular mortality, ‘lower is better’

By
Medhat

GEMINI-ACS-1: Bleeding with low-dose rivaroxaban versus aspirin after ACS

By
Medhat

SURTAVI Clinical Trial: TAVR vs surgical AVR

By
Medhat

SPIRE 1 and SPIRE 2: Safety and cardiovascular efficacy of bococizumab

By
Medhat

CARAT Study: Effect of CER-001 on coronary atherosclerosis

By
Medhat

Closed loop stimulation in recurrent reflex vasovagal syncope

By
Medhat

LAAO in AFib patients undergoing Cardiac Surgery

By
Medhat

ARISTOTLE: Digoxin in AFib with and without heart failure

By
Medhat

Dabigatran vs warfarin in patients undergoing catheter ablation of AFib

By
Medhat

Relationship between high troponin-T measurements and mortality

By
Medhat

Leaflet thrombosis in transcatheter and surgical bioprosthetic aortic valves

By
Medhat

Levosimendan in patients with LV dysfunction undergoing cardiac surgery

By
Medhat

Silent cerebral microbleeds during TAVR

By
Medhat

ACC 2017 wrap-up in German

By
Medhat

ACC 2017 wrap-up in Hebrew

By
Medhat

ACC 2017 wrap-up from the perspective of the pacific rim

By
Medhat

ACC 2017 wrap-up in Portuguese

By
Medhat

ACC 2017 wrap-up in Italian

By
Medhat

ACC 2017 wrap-up from the perspective of the Netherlands

By
Medhat

FFR guided acute complete revascularization vs culprit lesion only treatment in STEMI

By
Medhat